Sema4 and GNS Healthcare Announce Collaboration Using REFS™ Causal Machine Learning and Simulation AI Platform

By |

Working Towards New Therapies for Cardiovascular Disease   Stamford, Conn. and Cambridge, Mass. – June 27, 2017– Sema4, an interdisciplinary health information company with expertise in collecting diverse data, building computational models of disease and unlocking solutions to disease, today announced it is leveraging GNS Healthcare’s (GNS), REFS™ (Reverse Engineering…

Read More